Zylox-Tonbridge Medical Technology Co (FRA:818) Institutional Ownership: 8.44% (As of Aug. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:818 Zylox-Tonbridge Medical Technology Co Ltd FRA:818
76 GF Score
Price €2.08
GF Value €3.72
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Zylox-Tonbridge Medical Technology Co Institutional Ownership?

Zylox-Tonbridge Medical Technology Co FRA:818 -2.80% 76 Institutional Ownership is 8.44% as of Aug. 17, 2026. GuruFocus rates FRA:818 with a GF Score™ of 76/100 and a GF Value™ of €3.72 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Zylox-Tonbridge Medical Technology Co's institutional ownership is 8.44%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Zylox-Tonbridge Medical Technology Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Zylox-Tonbridge Medical Technology Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Zylox-Tonbridge Medical Technology Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Zylox-Tonbridge Medical Technology Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zylox-Tonbridge Medical Technology Co Institutional Ownership Chart

Zylox-Tonbridge Medical Technology Co Historical Data

The historical data trend for Zylox-Tonbridge Medical Technology Co can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 8.22 8.24 8.48 8.28 8.35 8.44 8.46 8.42 8.46 8.44
FRA:818
76GF Score
Zylox-Tonbridge Medical Technology Co Ltd FRA:818
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zylox-Tonbridge Medical Technology Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 8.44% mean?
Zylox-Tonbridge Medical Technology Co (FRA:818) has a Institutional Ownership of 8.44% as of Aug. 17, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Zylox-Tonbridge Medical Technology Co and its competitors.
Is Zylox-Tonbridge Medical Technology Co's Institutional Ownership too high?
Zylox-Tonbridge Medical Technology Co's current Institutional Ownership is 8.44%. Overall, Zylox-Tonbridge Medical Technology Co has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zylox-Tonbridge Medical Technology Co's Institutional Ownership compare to ABT and SYK?
Zylox-Tonbridge Medical Technology Co's Institutional Ownership of 8.44% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Zylox-Tonbridge Medical Technology Co and its competitors. Zylox-Tonbridge Medical Technology Co's current Institutional Ownership is 8.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zylox-Tonbridge Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Zylox-Tonbridge Medical Technology Co (FRA:818) is currently considered Significantly Undervalued. The stock's GF Value™ is €3.72, compared to a current price of €2.08 — trading 44.1% below its estimated fair value. The current Institutional Ownership is 8.44%. Zylox-Tonbridge Medical Technology Co's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Zylox-Tonbridge Medical Technology Co (FRA:818), the current Institutional Ownership is 8.44% as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zylox-Tonbridge Medical Technology Co (FRA:818) Overvalued in 2026?

Based on GuruFocus' analysis, Zylox-Tonbridge Medical Technology Co stock appears to be undervalued. The current stock price of €2.08 is trading 44.1% below its estimated GF Value™ of €3.72. GuruFocus considers Zylox-Tonbridge Medical Technology Co to be Significantly Undervalued.

Key valuation signals for FRA:818:

  • Institutional Ownership: 8.44%
  • GF Value™: €3.72 vs. price of €2.08 (44.1% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the FRA:818 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zylox-Tonbridge Medical Technology Co Business Description

Other Exchanges 02190:Hong Kong
Address 270 Shuyun Road, Cangqian Street, Zylox-Tonbridge Industrial Park, Yuhang District, Zhejiang Province, Hangzhou, CHN
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's products include Thrombite Clot Retriever Device (Thrombite CRD), Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB), and others. The company derives majority of its revenue from PRC.
76GF Score

Get the complete analysis for FRA:818

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.08
Price
€3.72
GF Value